Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : TAK crawled date : 2021 - 03 - 04 save search
Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
Published: 2020-09-11 (Crawled : 10:48) - investors.ovidrx.com
OVID | $3.245 1.09% 1.08% 180K
|
Health Technology
|
| O: 1.59%
H: 2.95%
C: -0.87%
Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies
Published: 2020-09-30 (Crawled : 10:48) - investors.ovidrx.com
OVID | $3.245 1.09% 1.08% 180K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: -5.12%
results rare
Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress
Published: 2020-10-12 (Crawled : 10:48) - investors.ovidrx.com
OVID | $3.245 1.09% 1.08% 180K
|
Health Technology
|
| O: 1.59%
H: 0.7%
C: -3.48%
Ovid Therapeutics to Host Educational Webinar on Angelman Syndrome and OV101 Development Program
Published: 2020-10-14 (Crawled : 10:48) - investors.ovidrx.com
OVID | $3.245 1.09% 1.08% 180K
|
Health Technology
|
| O: 1.22%
H: 0.7%
C: -2.23%
education syndros program
Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
Published: 2021-03-03 (Crawled : 10:48) - investors.ovidrx.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 2.03%
H: 1.14%
C: 0.68%
OVID | $3.245 1.09% 1.08% 180K
|
Health Technology
|
| O: 58.45%
H: 1.28%
C: -13.86%
treatment commercialization children syndros dravet syndrome
Enzyre announces strategic partnership with Takeda to accelerate development of pioneering diagnostic technology platform for hemophilia patients
Published: 2021-03-04 (Crawled : 09:10) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.45%
H: 0.85%
C: -1.08%
partnership diagnostic
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.